This invention relates to an improved process for the industrial
manufacture of S-adenosyl-L-methionine (SAMe) of formula (I), which
consists of stereo-selective methylation of S-adenosyl-L-homocysteine
(SAH) with the enrichment of active (S,S)-isomer.